CorMedica Group is dedicated to the development and advancement of cardiovascular monitoring technologies that provide increased accuracy and ease of use for physicians, and increased quality of care for patients.
“CorMedica’s goal is to provide one system that meets the diagnostic need of providers to easily monitor, diagnose, and treat patients while ensuring clinical and economic benefits for provider and patients alike.”
CorMedica’s suite of remote cardiac monitoring platforms are working to remove the burden from healthcare providers, hospitals, physicians, and patients, by helping doctors monitor patients’ cardiac health from the comfort of their own homes.
Because so much of cardiovascular monitoring takes place in clinics or hospitals, ECG effectiveness is limited by the available time and personnel resources.
CorMedica Group is a holding company, centered around the acquisition and growth of MedTech companies developing new and innovative AI-driven cardiovascular diagnostic technologies that align with our growing portfolio of software-as-a-service (SaaS) offerings for healthcare professionals and patients.
Our wholly owned subsidiary, Artella Solutions Inc., specializes in the development of ECG and remote cardiac monitoring devices, software, and analysis algorithms.
